【银诺医药-B(02591.HK):金柏获委任为公司副总裁】智通财经APP讯,银诺医药-B(02591.HK)发布公告,金柏先生已获委任为公司副总裁,主要负责集团整体产品商业化及相关其他事务,自2026年10月19日起生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.